Hims & Hers CEO Sells Shares in Routine Tax Withholding Transaction
Andrew Dudum, CEO of Hims & Hers Health (NASDAQ: HIMS), sold 78,859 shares on August 14 as part of a non-discretionary tax withholding transaction tied to the vesting of restricted stock units. The sale was valued at $2.2 million and does not reflect Dudum's personal view on the company’s future performance or valuation. The CEO holds both direct and indirect ownership through multiple entities, with total post-transaction holdings valued at approximately $272.32 million as of August 14. The stock had a one-year return of -40% prior to this event. Despite recent challenges including an FTC lawsuit and declining gross margins due to shifts in product mix, the company reported strong second-quarter revenue growth of 38%, reaching $753.2 million. Hims & Hers continues to operate as a leading digital health platform with a market cap of $6.4 billion and trailing twelve-month (TTM) revenue of $2.6 billion.
Tickers: $HIMS